NCT06274333View on ClinicalTrials.gov

Adding Dexmedetomidine or Tramadol to Paracetamol- An Effort to Attenuate Catheter Related Bladder Discomfort

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Percutaneous Nephrolithotripsy (PCNL)
Interventions
DRUG

Dexmedetomidine 0.5 mic/kg

Group I (DP group) will receive dexmedetomidine 0.5 mic/kg and paracetamol 10mg/kg,

DRUG

Tramadol 1mg/kg

Group II (TP group) will receive tramadol 1mg/kg and paracetamol 10mg/kg.

DRUG

Paracetamol 10mg/kg

Group I (DP group) will receive dexmedetomidine 0.5 mic/kg and paracetamol 10mg/kg. Group II (TP group) will receive tramadol 1mg/kg and paracetamol 10mg/kg.

Trial Locations (1)

11865

RECRUITING

Neveen Kohaf, Cairo

All Listed Sponsors
collaborator

Benha University

OTHER

lead

Al-Azhar University

OTHER